Minocycline inhibits inflammatory corpuscle mediated pyroptosis and improves cognitive ability in Alzheimer's disease mice

doi:10.12092/j.issn.1009-2501.2020.06.004

Abstract

Abstract: AIM: To study the mechanism of minocycline (Mino) in inhibiting inflammatory corpuscle NLRP3-mediated pyroptosis and improving cognitive ability in Alzheimer's disease. METHODS: Lipopolysaccharide (LPS) was used to induce PC12 to construct a model of neuronal pyroptosis. The cells were divided into control group, LPS group and LPS+Mino group. CCK-8 assay was used to detect cell viability, flow cytometry was used to detect apoptotic level, and Western blot was used to detect the levels of key proteins NLRP3, ASC, Caspase-1 and pro-Caspase-1 in NLRP3 corpuscles, as well as the levels of GSDMD and p30-GSDMD. Enzyme-linked immunosorbent assay was used to detect the expression of interleukin-1β, interleukin-18 and tumor necrosis factor-α in culture medium. APP-PS1 mice were randomly divided into control group and experimental group. The experimental group was given intragastric administration of minocycline 50 μg. The cognitive and memory abilities of mice were tested by Morris test before and 3 weeks after administration. The expressions of NLRP3, ASC, Caspase-1 and pro-Caspase-1 in hippocampal CA3 region were detected after execution, and the expressions of inflammatory factors such as IL-1β, IL-18 and TNF-α were detected. RESULTS: Minocycline could inhibit LPS-induced pyroptosis. Cell viability in LPS+Mino group was significantly higher than that in LPS group, and the apoptotic rate was significantly lower than that in LPS group (P<0.05). The expression of NLRP3, ASC and Caspase-1 in LPS+Mino group was lower than that in LPS group, while the expression of p30-GSDMD was lower than that in LPS group, and GSDMD was higher than that in LPS group. The levels of IL-1β, IL-18 and TNF-α in culture medium were lower than those in LPS group, with significant difference (P<0.05). In animal experiments, minocycline could significantly improve the cognitive ability of mice. In Morris experiment, the latency of mice was shortened, which had statistical significance compared with the control group (P<0.05). At the same time, the number of times of mice crossing the platform increased significantly compared with the control group (P<0.05). The expression of key proteins NLRP3, ASC and Caspase-1 in NLRP3 corpuscle of mice in experimental group was lower than that in control group, while the expression of pyroptosis executive protein p30-GSDMD was lower than that in control group, GSDMD was higher than that in control group, and the levels of inflammatory factors IL-1β, IL-18 and TNF-α were lower than that in control group (P<0.05). CONCLUSION: Minocycline can inhibit the activation of NLRP3 corpuscle and the occurrence of neuronal pyroptosis, and improve the cognitive ability of mice with Alzheimer's disease.

Key words: minocycline, Alzheimer's disease, inflammatory corpuscle, pyroptosis

CLC Number:

R965.2

SHENG Yongjia, LI Wenyan, ZHU Diwei, WANG Jin, GU Yanling. Minocycline inhibits inflammatory corpuscle mediated pyroptosis and improves cognitive ability in Alzheimer's disease mice[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(6): 625-632.

References 17

[1]	Blass JP, Ko LW, Wisniewski HM. Pathology of Alzheimer's disease [J]. Psy Clin North Am, 1991, 14(2): 397-420. DOI: 10.1016/S0193-953X (18)30315-0.
[2]	Imbimbo BP, Lombard J, Pomara N. Pathology of Alzheimer's disease [J]. Neuroimaging Clin N Am, 2011, 15(4): 727-753. DOI: 10.1016/j.nic.2005.09.009.
[3]	Sato N, Morishita R. Brain alterations and clinical symptoms of dementia in diabetes: Aβ/Tau-dependent and independent mechanisms [J]. Front Endocrinol, 2014, 5-12. DOI: 10.3389/fendo.2014.00143.
[4]	Tian M, Deng YY, Hou DR, et al. Association of IL-1, IL-18, and IL-33 gene polymorphisms with late-onset Alzheimer's disease in a Hunan Han Chinese population[J]. Brain Res, 2015, 1596: 136-145. DOI: 10.1016/ j.brainres.2014.11.019.
[5]	Finsen B.Expression of IL1β and TNF-α in Alzheimer's pathology in mice [J]. Alzheimers Dement, 2011, 7(4): S685-S685. DOI: 10.1016/j.jalz.2011.05.1977.
[6]	Liu Z, Gan L, Xu Y, et al. Melatonin alleviates inflammasome-induced pyroptosis through inhibiting NF-κB/GSDMD signal in mice adipose tissue [J]. J Pineal Res, 2017: e12414. DOI: 10.1111/jpi.12414.
[7]	Lim Y, Kumar S. A single cut to pyroptosis [J]. Oncotarget, 2015, 6(35): 36926-36927. DOI: 10.18632/oncotarget.6142.
[8]	Thangaraju P, Venkatesan S, Showkath Ali MK. Minocycline: A strategy for unresponsive nerve function impairment [J]. Dermatol Thera, 2017, 30(6): e12535. DOI: 10.1111/dth.12535.
[9]	Lauretti E, Domenico Praticò. Effect of canola oil consumption on memory, synapse and neuropathology in the triple transgenic mouse model of Alzheimer's disease [J]. Scient Rep, 2017, 7(1): 17134-17140. DOI: 10.1038/ s41598-017-17373-3.
[10]	Lin F, Ren P, Lo RY, et al. Insula and inferior frontal Gyrus' activities protect memory performance against Alzheimer's disease pathology in old age [J]. J Alzh Dis, 2017, 55(2): 669-675. DOI: 10.3233/JAD-160715.
[11]	SaNchez L, Madurga S, Pukala T, et al. Aβ40 and Aβ42 amyloid fibrils exhibit distinct molecular recycling properties[J]. J Am Chem Soc, 2011, 133(17): 6505-6508. DOI: 10.1021/ja1117123.
[12]	Horsburgh K, Cole GM, Yang F, et al. β-myloid (Aβ) 42 (43), Aβ42, Aβ40 and apoE immunostaining of plaques in fatal head injury [J]. Neuropathol Appl Neurobiol, 2000, 26(2): 124-132. DOI: 10.1046/j.1365-2990.2000.026002124.x.
[13]	Mridha AR, Wree A, Robertson AAB, et al. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice [J]. J Hepatol, 2017, 66(5): 1037-1046. DOI: 10.1016/j.jhep.2017.01.022.
[14]	Wang Z, Meng S, Cao L, et al. Critical role of NLRP3-caspase-1 pathway in age-dependent isoflurane-induced microglial inflammatory response and cognitive impairment [J]. J Neuroinflamm, 2018, 15(1): 109-115. DOI: 10.1186/s12974-018-1137-1.
[15]	Chen H, Lu Y, Cao Z, et al. Cadmium induces NLRP3 inflammasome-dependent pyroptosis in vascular endothelial cells [J]. Toxicol Lett, 2016, 246: 7-16. DOI: 10.1016/j.toxlet.2016.01.014.
[16]	潘贺, 潘丽红, 张予阳. 米诺环素对脑缺血后的神经保护作用及其机制 [J]. 沈阳药科大学学报, 2011, 28(4): 325-329.
[17]	王鑫, 陈艳平, 曹德权, 等. 米诺环素对神经病理性疼痛大鼠脊髓水平OX-42表达的影响 [J]. 中国疼痛医学杂志, 2009, 15(1): 30-34.